General Information of the Compound
Compound ID
CP0857561
Compound Name
(3S)-4-[[(9R,15S,18S,21S,24S,30S,33S,36R,39S,42S,48S,54S,57S,60R)-24-(2-amino-2-oxoethyl)-60-[[(2S)-1-amino-1-oxopropan-2-yl]carbamoyl]-57-[(1R)-1-hydroxyethyl]-42-(1H-imidazol-4-ylmethyl)-54-(1H-indol-3-ylmethyl)-33,39-bis(2-methylpropyl)-4,10,16,19,22,25,31,34,37,40,43,49,52,55,58,65,68-heptadecaoxo-18-(2-phenylethyl)-21-propan-2-yl-7,62,71-trithia-1,3,11,17,20,23,26,32,35,38,41,44,50,53,56,59,66-heptadecazahexacyclo[34.31.5.13,66.011,15.026,30.044,48]triheptacontan-9-yl]amino]-3-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoic acid
    Show/Hide
Structure
Formula
C106H156N30O26S3
Molecular Weight
2362.799
Canonical SMILES
CC(C)C[C@@H]1NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCc3ccccc3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC1=O
    Show/Hide
InChI
InChI=1S/C106H156N30O26S3/c1-55(2)39-68-92(149)124-72(42-63-46-112-51-116-63)103(160)134-33-16-24-77(134)98(155)115-47-81(139)118-70(41-62-45-114-65-22-14-13-21-64(62)65)95(152)130-87(60(9)137)102(159)127-74(96(153)117-59(8)88(109)145)48-163-36-29-82(140)131-52-132-54-133(53-131)84(142)31-38-165-50-76(128-94(151)71(44-85(143)144)122-90(147)66(119-89(146)58(7)107)23-15-32-113-106(110)111)105(162)136-35-18-25-78(136)99(156)120-67(28-27-61-19-11-10-12-20-61)91(148)129-86(57(5)6)101(158)125-73(43-80(108)138)104(161)135-34-17-26-79(135)100(157)123-69(40-56(3)4)93(150)126-75(97(154)121-68)49-164-37-30-83(132)141/h10-14,19-22,45-46,51,55-60,66-79,86-87,114,137H,15-18,23-44,47-50,52-54,107H2,1-9H3,(H2,108,138)(H2,109,145)(H,112,116)(H,115,155)(H,117,153)(H,118,139)(H,119,146)(H,120,156)(H,121,154)(H,122,147)(H,123,157)(H,124,149)(H,125,158)(H,126,150)(H,127,159)(H,128,151)(H,129,148)(H,130,152)(H,143,144)(H4,110,111,113)/t58-,59-,60+,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,86-,87-/m0/s1
    Show/Hide
InChIKey
YZSGKBXGZWXRIE-YRCSROHESA-N
Physicochemical Property
logP
-6.45083
Rotatable Bonds
30
Heavy Atom Count
165
Polar Areas
834.46
Hydrogen Bond Donor Count
25
Hydrogen Bond Acceptor Count
31
Complexity
165

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 156014581
ChEMBL ID
CHEMBL4635897
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01335, Ephrin type-A receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 14.5 nM
   TI
   LI
   LO
   TS